Does anyone worry at all about Abbott splitting up and what the impact will be on Neurocrine?
I sure would like to see the Elagolix trial get underway in endo. The uterine fibroids study launched but it's tiny. I'm looking forward to the update this Thursday. We need to get a better idea of when this trial will launch.